You are using an older browser version. Please use a supported version for the best MSN experience.

ROCKWELL MEDICAL, INC.

NASDAQ: RMTI
4.72
-0.06
-1.26%

Sector

Healthcare

Industry

Pharmaceuticals

Rockwell Medical, Inc. (Rockwell) is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The Company operates through the hemodialysis market segment, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceutical, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. The Company's drug products include Triferic (ferric pyrophosphate citrate) and Calcitriol (Active Vitamin D) Injection. Triferic is an iron compound that is delivered to hemodialysis patients through dialysate, replacing the iron loss that occurs during their dialysis treatment. Calcitriol (active vitamin D) injection is indicated for treatment of secondary hyperparathyroidism in dialysis patients.

Key People

Benjamin Wolin

Chairman of the Board

David Kull

Principal Accounting Officer

Ajay Gupta

Chief Scientific Officer

Raymond Pratt

Chief Medical Officer

Robert Chioini

Director

  • Rockwell Medical Inc

  • 30142 S Wixom Rd

  • WIXOM, MI 48393-3440

  • US.Map

  • Phone: +1 248 9609009

  • Fax: +1 248 9609119

  • rockwellmed.com

Incorporated

1996

Employees

269

Insider Trades
  • Recent
  • All
  • Date

  • Name

  • Transaction

  • Shares

  • Price(s)

  • Value

    • 5/9/2019

    • RICHMOND DAVID S.

    • Bought

    • 4,643

    • 5.65

    • 26,211.13

    • 4/25/2019

    • PRATT RAYMOND DENNIS

    • Grant

    • 40,000

    • NA

    • NA

    • 4/25/2019

    • KULL DAVID

    • Grant

    • 10,000

    • NA

    • NA

    • 4/25/2019

    • GUPTA AJAY

    • Grant

    • 17,000

    • NA

    • NA

    • 3/27/2019

    • RICHMOND DAVID S.

    • Bought

    • 5,869

    • 5.59

    • 32,788.34

    • 11/28/2018

    • SMITH ANGUS W

    • Grant

    • 166,667

    • NA

    • NA

    • 10/15/2018

    • RICHMOND DAVID S.

    • Bought

    • 5,541,562

    • 4.29

    • 23,773,300.98

    • 10/5/2018

    • GUPTA AJAY

    • Grant

    • 100,000

    • NA

    • NA

    • 9/20/2018

    • KULL DAVID

    • NA

    • 5,000

    • 3.09

    • 15,450.00

    • 9/4/2018

    • PAUL STUART M

    • Grant

    • 388,125

    • NA

    • NA

    • 6/27/2018

    • RICHMOND DAVID S.

    • Bought

    • 12,561

    • 4.73

    • 59,413.53

    • Date

    • Name

    • Transaction

    • Shares

    • Price(s)

    • Value

      • 5/9/2019

      • RICHMOND DAVID S.

      • Bought

      • 4,643

      • 5.65

      • 26,211.13

      • 4/25/2019

      • PRATT RAYMOND DENNIS

      • Grant

      • 40,000

      • NA

      • NA

      • 4/25/2019

      • KULL DAVID

      • Grant

      • 10,000

      • NA

      • NA

      • 4/25/2019

      • GUPTA AJAY

      • Grant

      • 17,000

      • NA

      • NA

      • 3/27/2019

      • RICHMOND DAVID S.

      • Bought

      • 5,869

      • 5.59

      • 32,788.34

      • 11/28/2018

      • SMITH ANGUS W

      • Grant

      • 166,667

      • NA

      • NA

      • 10/15/2018

      • RICHMOND DAVID S.

      • Bought

      • 5,541,562

      • 4.29

      • 23,773,300.98

      • 10/5/2018

      • GUPTA AJAY

      • Grant

      • 100,000

      • NA

      • NA

      • 9/20/2018

      • KULL DAVID

      • NA

      • 5,000

      • 3.09

      • 15,450.00

      • 9/4/2018

      • PAUL STUART M

      • Grant

      • 388,125

      • NA

      • NA

      • 6/27/2018

      • RICHMOND DAVID S.

      • Bought

      • 12,561

      • 4.73

      • 59,413.53

      AdChoices
      AdChoices
      AdChoices
      image beaconimage beaconimage beacon